Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1994 | 09-1994 | 06-1994 | 03-1994 | 12-1993 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,655 | N/A | N/A | N/A | -39,884 |
| Depreciation Amortization | 4,095 | N/A | N/A | N/A | 3,101 |
| Other Working Capital | -4,168 | N/A | N/A | N/A | 3,226 |
| Other Operating Activity | 10,209 | 0 | 0 | 0 | 3,422 |
| Operating Cash Flow | $-20,519 | $N/A | $N/A | $N/A | $-30,135 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,948 | N/A | N/A | N/A | -10,201 |
| Other Investing Activity | 38,814 | 0 | 0 | 0 | -13,381 |
| Investing Cash Flow | $31,866 | $N/A | $N/A | $N/A | $-23,582 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -235 | 0 | 0 | 0 | 49,812 |
| Financing Cash Flow | $-235 | $N/A | $N/A | $N/A | $49,812 |
| Beginning Cash Position | 12,533 | N/A | N/A | N/A | 16,438 |
| End Cash Position | 23,646 | N/A | N/A | N/A | 12,533 |
| Net Cash Flow | $11,113 | $N/A | $N/A | $N/A | $-3,905 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,519 | N/A | N/A | N/A | -30,135 |
| Free Cash Flow | -20,519 | 0 | 0 | 0 | -30,135 |